| Kfir Ben-david, MD | |
|
4306 Alton Rd Fl 2, Miami Beach, FL 33140-2840 | |
| (305) 674-2397 | |
| (305) 674-2863 |
| Full Name | Kfir Ben-david |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 23 Years |
| Location | 4306 Alton Rd Fl 2, Miami Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144234881 | NPI | - | NPPES |
| 278808000 | Medicaid | FL | |
| 142UG | Other | NC | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 200600755 (North Carolina) | Secondary |
| 208600000X | Surgery | ME98890 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Sinai Medical Center | Miami beach, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physician Practices Of Msmc Llc | 9436336120 | 129 |
News Archive
Roche Diagnostics announced today that the U.S. Food and Drug Administration (FDA) granted Premarket Approval for its Elecsys Antibody to hepatitis C virus (anti-HCV) assay. The Elecsys Anti-HCV assay is an in-vitro diagnostic test for the qualitative detection of total antibodies to hepatitis C virus in human serum or plasma.
Some low-income consumers who bought bronze plans with low premiums but high deductibles are discovering they still can't afford health care and are turning to the community health centers which can not turn anyone away.
John DeLuca, PhD, VP for Research at Kessler Foundation, will conduct a teleconference, "Where is my Memory? Cognitive Changes in MS," on Tues., January 24, 6:30-7:30 pm. Dr. DeLuca is well known for his neuropsychology research in cognition and multiple sclerosis and is a licensed psychologist in New Jersey and New York.
Pfizer Inc, the world's leading biopharmaceutical company, today announced that the results of a number of hemophilia studies will be presented at the World Federation of Hemophilia 2010 Congress taking place July 10-14, 2010, in Buenos Aires, Argentina. Key research includes a pre-clinical evaluation of recombinant factor Xa as a potential new approach to restoring hemostasis, as well as a study assessing the potential for an engineered recombinant factor VIIa molecule to improve therapeutic outcomes in mouse models of hemophilia.
The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.
› Verified 9 days ago
| Entity Name | Physician Practices Of Msmc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356630628 PECOS PAC ID: 9436336120 Enrollment ID: O20110606000715 |
News Archive
Roche Diagnostics announced today that the U.S. Food and Drug Administration (FDA) granted Premarket Approval for its Elecsys Antibody to hepatitis C virus (anti-HCV) assay. The Elecsys Anti-HCV assay is an in-vitro diagnostic test for the qualitative detection of total antibodies to hepatitis C virus in human serum or plasma.
Some low-income consumers who bought bronze plans with low premiums but high deductibles are discovering they still can't afford health care and are turning to the community health centers which can not turn anyone away.
John DeLuca, PhD, VP for Research at Kessler Foundation, will conduct a teleconference, "Where is my Memory? Cognitive Changes in MS," on Tues., January 24, 6:30-7:30 pm. Dr. DeLuca is well known for his neuropsychology research in cognition and multiple sclerosis and is a licensed psychologist in New Jersey and New York.
Pfizer Inc, the world's leading biopharmaceutical company, today announced that the results of a number of hemophilia studies will be presented at the World Federation of Hemophilia 2010 Congress taking place July 10-14, 2010, in Buenos Aires, Argentina. Key research includes a pre-clinical evaluation of recombinant factor Xa as a potential new approach to restoring hemostasis, as well as a study assessing the potential for an engineered recombinant factor VIIa molecule to improve therapeutic outcomes in mouse models of hemophilia.
The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kfir Ben-david, MD 4306 Alton Rd, Miami Beach, FL 33140-2840 Ph: (305) 535-3349 | Kfir Ben-david, MD 4306 Alton Rd Fl 2, Miami Beach, FL 33140-2840 Ph: (305) 674-2397 |
News Archive
Roche Diagnostics announced today that the U.S. Food and Drug Administration (FDA) granted Premarket Approval for its Elecsys Antibody to hepatitis C virus (anti-HCV) assay. The Elecsys Anti-HCV assay is an in-vitro diagnostic test for the qualitative detection of total antibodies to hepatitis C virus in human serum or plasma.
Some low-income consumers who bought bronze plans with low premiums but high deductibles are discovering they still can't afford health care and are turning to the community health centers which can not turn anyone away.
John DeLuca, PhD, VP for Research at Kessler Foundation, will conduct a teleconference, "Where is my Memory? Cognitive Changes in MS," on Tues., January 24, 6:30-7:30 pm. Dr. DeLuca is well known for his neuropsychology research in cognition and multiple sclerosis and is a licensed psychologist in New Jersey and New York.
Pfizer Inc, the world's leading biopharmaceutical company, today announced that the results of a number of hemophilia studies will be presented at the World Federation of Hemophilia 2010 Congress taking place July 10-14, 2010, in Buenos Aires, Argentina. Key research includes a pre-clinical evaluation of recombinant factor Xa as a potential new approach to restoring hemostasis, as well as a study assessing the potential for an engineered recombinant factor VIIa molecule to improve therapeutic outcomes in mouse models of hemophilia.
The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.
› Verified 9 days ago
Dr. Rodrigo Arrangoiz, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4306 Alton Rd Fl 2, Miami Beach, FL 33140 Phone: 305-674-2397 Fax: 305-674-2863 | |
Dr. Sharone Marie Jacobs, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 300 71st St, Suite 620, Miami Beach, FL 33141 Phone: 305-866-9951 Fax: 877-284-8933 | |
Dr. Manuel Viamonte Iii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4306 Alton Rd Fl 3, Miami Beach, FL 33140 Phone: 305-674-2177 Fax: 305-674-2176 | |
Dr. Sumana Narayanan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4306 Alton Rd, Miami Beach, FL 33140 Phone: 305-674-2397 | |
Luis Enrique Rosario Alvarado, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 4300 Alton Rd, Miami Beach, FL 33140 Phone: 305-674-2682 | |
Irving Jorge, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4302 Alton Rd, Suite 540, Miami Beach, FL 33140 Phone: 305-674-2151 Fax: 305-674-2859 | |
Dr. Gary Lewis Glick, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 4308 Alton Rd, Suite 410, Miami Beach, FL 33140 Phone: 305-672-6100 Fax: 305-532-7444 |